What test is used to confirm syphilis after a positive Rapid Plasma Reagin (RPR) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Confirmatory Testing After Positive RPR for Syphilis

After a positive Rapid Plasma Reagin (RPR) test for syphilis, a treponemal test such as the Treponema pallidum particle agglutination (TP-PA) assay or fluorescent treponemal antibody absorption (FTA-ABS) test should be performed to confirm the diagnosis. 1

Understanding Syphilis Testing Algorithms

Syphilis diagnosis involves two types of tests:

  1. Nontreponemal tests (RPR, VDRL)

    • Detect antibodies to cardiolipin
    • Can produce false-positive results
    • Used for screening and monitoring treatment response
  2. Treponemal tests (TP-PA, FTA-ABS)

    • Detect antibodies specific to T. pallidum
    • Higher sensitivity (95-100%) and specificity (95-100%)
    • Used for confirmation of infection

Traditional Algorithm

  • Initial screening with nontreponemal test (RPR)
  • If positive, confirm with treponemal test (TP-PA or FTA-ABS)

Reverse Algorithm

  • Initial screening with treponemal test
  • If positive, follow with nontreponemal test for activity assessment

Confirmatory Treponemal Tests

The CDC recommends the following treponemal tests for confirmation after a positive RPR 2:

  • TP-PA (Treponema pallidum particle agglutination) - Highly sensitive and specific
  • FTA-ABS (Fluorescent treponemal antibody absorption) - Traditional gold standard
  • EIA/CIA (Enzyme/Chemiluminescence immunoassay) - Automated options

Interpreting Results

RPR Result Treponemal Test Result Interpretation
Positive Positive Confirmed syphilis (current or past)
Positive Negative Likely false-positive RPR

False-Positive RPR Considerations

  • More common in women than men (0.27% vs 0.20%) 1
  • Higher in patients over 60 years (0.34%) 1
  • More frequent in HIV-infected persons 2
  • Can occur in autoimmune diseases, pregnancy, and other infections

Special Situations

  • Suspected false-negative treponemal test: Consider repeat testing in 1-2 weeks, exclusion of prozone phenomenon, biopsy, darkfield examination, or direct fluorescent antibody staining 2

  • Discordant results: When initial treponemal test and follow-up nontreponemal test are discordant, additional treponemal testing with a different method may be helpful 1, 3

  • Suspected neurosyphilis: CSF examination should be performed in persons with neurologic or ocular symptoms, active tertiary syphilis, treatment failure, or HIV-infected persons with late-latent syphilis 2

Newer Testing Options

While traditional treponemal tests remain the standard for confirmation, newer options include:

  • Western blot/Immunoblot assays: High sensitivity and specificity, useful for resolving discordant results 4
  • Point-of-care dual tests: Simultaneously detect both nontreponemal and treponemal antibodies 5

Key Pitfalls to Avoid

  • Don't rely solely on RPR results - False positives occur in 0.2-0.34% of the population 1
  • Don't confuse past treated infection with current infection - Treponemal tests typically remain positive for life after infection
  • Don't overlook the possibility of neurosyphilis - Consider CSF examination in appropriate cases
  • Don't miss early syphilis - Serologic tests may be negative in very early primary syphilis

Remember that while treponemal tests are highly specific for syphilis, they cannot distinguish between current and past treated infections. The nontreponemal test titer is used to monitor disease activity and treatment response.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.